“…Recently, advanced cancer therapies have gained traction as an alternative to traditional treatment methods . Immunotherapy against cancer, in particular, is garnering attention for its ability to use the body’s immune cells to eradicate cancer cells. − By activating dendritic cells (DCs) against cancer antigens, immunotherapy can elicit antigen-specific T cell immunity, which selectively kills cancer cells expressing the antigen . Additionally, activated T cells can remember antigens, which may inhibit metastasis and recurrence. ,, However, selecting cancer antigens is challenging due to the heterogeneity of individual cancers, and many cancer antigens lack immune activation ability. ,, Consequently, various methods are being explored for cancer immunotherapy including thermal immunotherapy, which has shown promise in achieving efficient cancer therapy. − Inorganic nanoparticles have been widely used due to their ability to generate thermal effects. − However, the availability of biocompatible and safe inorganic nanoparticles remains limited, and the high local concentration of these nanoparticles is also crucial for achieving an efficient thermal effect.…”